Monday, November 14, 2016
- 9:00AM-11:00AM
-
Abstract Number: 1726
An Integrated Safety Data Analysis Across All Phase II and Phase III Clinical Programs for Ustekinumab in Psoriatic Arthritis, Crohn’s Disease, and Psoriasis
Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster II: Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 1577
An Investigation of Translocator Protein As a Tissue and Peripheral Blood Biomarker of Inflammation in Rheumatoid Arthritis
Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1625
Analysis of a Phase 3 Study Evaluating the Efficacy of Sirukumab, an Anti-IL-6 Cytokine Monoclonal Antibody, Across Subgroups in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs
Rheumatoid Arthritis – Small Molecules, Biologics and Gene Therapy - Poster II- 9:00AM-11:00AM
-
Abstract Number: 1301
Analysis of Anatomical Sites Causing Dactylitis and Their Responsiveness to Change Under TNF-Therapy in Psoriatic Arthritis By High Resolution MRI
Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI- 9:00AM-11:00AM
-
Abstract Number: 1781
Analysis of Influences of Various Factors on the Prognosis of Acute Confusional State of Diffuse Psychiatric/Neuropsychological Syndromes in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life- 9:00AM-11:00AM
-
Abstract Number: 1937
Analysis of Innate and Adaptive Immune Responses in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
Vasculitis - Poster II: ANCA-Associated Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1776
Analysis of Progressive Brain and Corpus Callosum Atrophy and Association with Th1 and Th2 Cytokines in Systemic Lupus Erythematosus
Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life- 9:00AM-11:00AM
-
Abstract Number: 1919
Analysis of T Cell Repertoire Diversity of CD4+ Memory and NaïVe T Cells By Next Generation Sequencing and Its Association with Rheumatoid Arthritis Disease Parameters
T Cell Biology and Targets in Autoimmune Disease - Poster Session I- 9:00AM-11:00AM
-
Abstract Number: 1086
Analysis of the Naive B Cell Repertoire in Belimumab Treated SLE Patients
B Cell Biology and Targets in Autoimmune Disease - Poster I: SLE and Sjögren's- 9:00AM-11:00AM
-
Abstract Number: 1307
Anatomical Patterns Suggest the Involvement of Biomechanical Stress in the Pathogenesis of Erosions in Rheumatoid Arthritis
Imaging of Rheumatic Diseases - Poster II: XR/CT/PET/MRI- 9:00AM-11:00AM
-
Abstract Number: 1950
ANCA-Associated Vasculitides and IgG4-Related Disease: An Overlapping Syndrome? a European Observational Study of 18 Patients
Vasculitis - Poster II: ANCA-Associated Vasculitis- 9:00AM-11:00AM
-
Abstract Number: 1116
Anti-Citrullinated Protein Antibodies Promote Synovial Fibroblasts Migration and Adhesion through a Peptidylarginine Deiminases (PAD) Dependent Pathway
Cytokines, Mediators, Cell-Cell Adhesion, Cell Trafficking and Angiogenesis - Poster I- 9:00AM-11:00AM
-
Abstract Number: 1499
Anti-Cyclic Citrullinated Peptide Antibodies and Severity of Interstitial Lung Disease with Rheumatoid Arthritis
Rheumatoid Arthritis – Clinical Aspects - Poster II: Co-morbidities and Complications- 9:00AM-11:00AM
-
Abstract Number: 1128
Anti-Fractalkine Monoclonal Antibody Inhibits Cartilage Destruction and Bone Erosion in Collagen-Induced Arthritis Model